+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stroke Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • PDF Icon

    Report

  • 171 Pages
  • October 2019
  • Region: Global
  • Transparency Market Research
  • ID: 4911448
Stroke Treatment Market - Scope of the Report

the report on the global stroke treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall revenue of the global stroke treatment market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global stroke treatment market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global stroke treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study various phenomena in the global stroke treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global stroke therapy market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global stroke treatment market. The next section of the global stroke treatment report highlights the USPs, which include key industry developments in the global stroke treatment market, pipeline analysis, and epidemiology analysis of stroke.

The report delves into the competitive landscape of the global stroke treatment market. Key players operating in the global stroke treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global stroke treatment market report.

Key Questions Answered in Global Stroke Treatment Market Report

  • What are the major drivers, restraints, and opportunities in the market?
  • What are the revenue share projections of key segments of the global stroke treatment market for the forecast period?
  • Which segment is likely to lead the stroke treatment market in terms of revenue by 2027?
  • How are alliances & partnerships among players widening the scope for stroke treatment?
  • What is the market position of different companies operating in the global stroke treatment market?

Stroke Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global stroke treatment market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, and healthcare compliances laid down by accredited agencies in the purview of research in the global stroke treatment market. It is followed by the market introduction, market dynamics, and an overview of the global stroke treatment market, which includes an’s analysis of the market drivers, restraints, and trends affecting the growth of the global stroke treatment market. Furthermore, Y-o-Y analysis with elaborate insights have been provided to understand the Y-o-Y trends in the stroke treatment market. The next section of the global stroke treatment report highlights the USPs, which include the epidemiology analysis of stroke, pipeline analysis for stroke treatment, and key industry developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global Stroke Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Stroke Treatment Market Analysis and Forecast, 2017-2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Industry Developments
5.2. Pipeline Analysis
5.3. Epidemiology Analysis
6. Global Stroke Treatment Market Value and Forecast, by Type
6.1. Introduction & Definition
6.2. Global Stroke Treatment Market Value Forecast, by Type, 2017-2027
6.2.1. Ischemic Stroke
6.2.2. Hemorrhagic Stroke
6.3. Global Stroke Treatment Market Attractiveness, by Type
7. Global Stroke Treatment Market Value and Forecast, by Drug Class
7.1. Introduction & Definition
7.2. Global Stroke Treatment Market Value Forecast, by Drug Class, 2017-2027
7.2.1. Tissue Plasminogen Activator (tPA)
7.2.2. Anticoagulants
7.2.3. Antiplatelets
7.2.4. Anticonvulsants
7.2.5. Others
7.3. Global Stroke Treatment Market Attractiveness, by Drug Class
8. Global Stroke Treatment Market Value and Forecast, by Distribution Channel
8.1. Introduction
8.2. Global Stroke Treatment Market Value Forecast, by Distribution Channel, 2017-2027
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Global Stroke Treatment Market Attractiveness, by Distribution Channel
9. Global Stroke Treatment Market Value and Forecast, by Region
9.1. Introduction
9.2. Stroke Treatment Market Value Forecast, by Region, 2017-2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Stroke treatment Market Attractiveness, by Region
10. North America Stroke Treatment Market Analysis and Forecast
10.1. Introduction
10.2. North America Stroke Treatment Market Value Forecast, by Type, 2017-2027
10.2.1. Ischemic Stroke
10.2.2. Hemorrhagic Stroke
10.3. North America Stroke Treatment Market Value Forecast, by Drug Class, 2017-2027
10.3.1. Tissue Plasminogen Activator (tPA)
10.3.2. Anticoagulants
10.3.3. Antiplatelets
10.3.4. Anticonvulsants
10.3.5. Others
10.4. North America Stroke Treatment Market Value Forecast, by Distribution Channel, 2017-2027
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Stroke treatment Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Drug Class
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Stroke Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Europe Stroke Treatment Market Value Forecast, by Type, 2017-2027
11.2.1. Ischemic Stroke
11.2.2. Hemorrhagic Stroke
11.3. Europe Stroke Treatment Market Value Forecast, by Drug Class, 2017-2027
11.3.1. Tissue Plasminogen Activator (tPA)
11.3.2. Anticoagulants
11.3.3. Antiplatelets
11.3.4. Anticonvulsants
11.3.5. Others
11.4. Europe Stroke Treatment Market Value Forecast, by Distribution Channel, 2017-2027
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Europe Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Stroke treatment Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Drug Class
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Stroke Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Stroke Treatment Market Value Forecast, by Type, 2017-2027
12.2.1. Ischemic Stroke
12.2.2. Hemorrhagic Stroke
12.3. Asia Pacific Stroke Treatment Market Value Forecast, by Drug Class, 2017-2027
12.3.1. Tissue Plasminogen Activator (tPA)
12.3.2. Anticoagulants
12.3.3. Antiplatelets
12.3.4. Anticonvulsants
12.3.5. Others
12.4. Asia Pacific Stroke Treatment Market Value Forecast, by Distribution Channel, 2017-2027
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Asia Pacific Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Stroke treatment Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Drug Class
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Stroke Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Stroke Treatment Market Value Forecast, by Type, 2017-2027
13.2.1. Ischemic Stroke
13.2.2. Hemorrhagic Stroke
13.3. Latin America Stroke Treatment Market Value Forecast, by Drug Class, 2017-2027
13.3.1. Tissue Plasminogen Activator (tPA)
13.3.2. Anticoagulants
13.3.3. Antiplatelets
13.3.4. Anticonvulsants
13.3.5. Others
13.4. Latin America Stroke Treatment Market Value Forecast, by Distribution Channel, 2017-2027
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Latin America Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Stroke treatment Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Drug Class
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Stroke treatment Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Stroke Treatment Market Value Forecast, by Type, 2017-2027
14.2.1. Ischemic Stroke
14.2.2. Hemorrhagic Stroke
14.3. Middle East & Africa Stroke Treatment Market Value Forecast, by Drug Class, 2017-2027
14.3.1. Tissue Plasminogen Activator (tPA)
14.3.2. Anticoagulants
14.3.3. Antiplatelets
14.3.4. Anticonvulsants
14.3.5. Others
14.4. Middle East & Africa Stroke Treatment Market Value Forecast, by Distribution Channel, 2017-2027
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Stroke treatment Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Drug Class
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Stroke Treatment Market Position Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Bristol-Myers Squibb Company
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Boehringer Ingelheim GmbH
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. Financial Overview
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Daiichi Sankyo Company, Limited
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. Financial Overview
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. F. Hoffmann-La Roche Ltd
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Johnson & Johnson Services, Inc.
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. Financial Overview
15.2.5.4. Strategic Overview
15.2.5.5. SWOT Analysis
15.2.6. Sanofi
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Amgen, Inc.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. Financial Overview
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. Biogen Inc.
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. Financial Overview
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. AstraZeneca
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. Financial Overview
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company, Limited
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc.
  • Sanofi
  • Amgen, Inc.
  • Biogen Inc.
  • AstraZeneca